Ortho-McNeil-Janssen Pharmaceuticals, Inc. F/k/a Janssen Pharmac — Danielson, J., Concurring in Part and Dissenting…

Summary

The opinion concurs with reversal and dismissal of the State’s MFFCA claim because the statutory language must be read as a whole and does not encompass the claim. It dissents from the conclusion that the DDMAC warning letter was inadmissible hearsay, reasoning that the letter fell within the public-records exception because it resulted from the agency’s routine regulatory duties rather than a special investigation. The opinion would therefore affirm the circuit court’s denial of the motion in limine.